Some Researchers Are Pleased, Others Indifferent, As RU 486 Moves Toward Ready Availability In U.S.

Some Researchers Are Pleased, Others Indifferent, As RU 486 Moves Toward Ready Availability In U.S. Author: KAREN YOUNG KREEGER, pp.1 Date: August 22,1994 Biomedical researchers working with the antiprogestin RU 486 are expressing varied opinions on the mid-May announcement that the controversial drug will eventually be more readily available in the United States and how that availability may affect their investigations. Some scie

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Some Researchers Are Pleased, Others Indifferent, As RU 486 Moves Toward Ready Availability In U.S. Author: KAREN YOUNG KREEGER, pp.1
Date: August 22,1994

Biomedical researchers working with the antiprogestin RU 486 are expressing varied opinions on the mid-May announcement that the controversial drug will eventually be more readily available in the United States and how that availability may affect their investigations.

Some scientists consider the transfer by Roussel Uclaf--the Paris-based manufacturer of RU 486--of U.S. patent rights, free of charge, to the Population Council, a New York-based contraception research group, to be very good news concerning the drug's use in the U.S., both as an abortifacient and in biomedical research.

"I believe that when the compound is freely available [in the U.S.], more people will study it," says Leslie Z. Benet, a professor of pharmacy and pharmacological chemistry at the University of California, San Francisco.

Researchers such as Benet say ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Karen Kreeger

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio 
Zymo Research

Zymo Research Launches Microbiome Grant to Support Innovation in Microbial Sciences